ジピリダモールの多剤耐性克服作用に関する研究(第1報)ジピリダモールによるエピルビシンの細胞増殖, 細胞周期に対する作用の修飾

概要

論文の詳細を見る
Dipyridamole, a nucleoside membrane transport inhibitor, enhanced the cytotoxicity of epirubicin for mouse leukemia P388 cells by a factor of 1.8-fold and that for 30-fold doxorubicin-resistant sublines of P388 cells (P388/DOX) by a factor of 6.5-fold. This interaction was shown to be truly synergistic by DNA histogram and median effect analysis. The dipyridamole enhancement of the cytotoxicity of epirubicin was a dose-dependent effect ; it was greatest when cells were exposed to dipyridamole before treatment with epirubicin. In cell cycle experiments, 1-5μM dipyridamole increased the accumulation of G_2+M phase produced by the treatment with 0.5-1μM epirubicin. Dipyridamole, however, did not appear to alter the patterns of DNA histogram in sensitive cells. These results suggest that the increase of the accumulation of G_2+M phase in resistant cells is an important factor for the interaction between epirubicin and dipyridamole.
社団法人日本薬学会の論文
1996-03-25